Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J07 VACCINES
J07B VIRAL VACCINES
J07BN Covid-19 vaccines
J07BN02 Covid-19, viral vector, non-replicating
D12115 COVID-19 vaccine (ChAdOx1-S [recombinant])
USP drug classification [BR:br08302]
Immunological Agents
Vaccines
COVID-19
COVID-19 Vaccine (Subunit)
D12115 COVID-19 vaccine (ChAdOx1-S [recombinant])
Drug groups [BR:br08330]
Antiviral
DG03172 COVID-19 vaccine
D12115 COVID-19 vaccine (ChAdOx1-S [recombinant])
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D12115
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D12115
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D12115